| [1] |
Petersen RC,Smith GE,Waring SC,et al.Mild cognitive impairment:clinical characterization and outcome.Arch Neurol,1999,6(3):303-308.
|
| [2] |
Petersen RC,Doody R,Kurz A,et al.Current concepts in mild cognitive impairment.Arch Neurol,2001,58(12):1985-1992.
|
| [3] |
Celsis P.Age-related cognitive decline,mild cognitive impairment or preclinical Alzheimer's disease?.Ann Med,2000,32(1):6-14.
|
| [4] |
Bennett DA,Schneider JA,Bienias JL,et al.Mild cognitive impairment is related to Alzheimer's disease pathology and cerebral infarctions.Neurology,2005,64(5):834-841.
|
| [5] |
Johnson NA,Jahng GH,Weiner MW,et al.Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging:initial experience.Radiology,2005,234(3):851-859.
|
| [6] |
Kantarci K,Jack CR Jr,Xu YC,et al.Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease:A 1H MRS study.Neurology.2000,55(2):210-217.
|
| [7] |
Kantarci K,Peterson RC,Boeve BF,et al.DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment.Neurology,2005,64(5):902-904.
|
| [8] |
Machulda MM,Ward HA,Borowski B,et al.Comparison of memory fMRI response among normal,MCI,and Alzheimer's patients.Neurology,2003,61(4):500-506.
|
| [9] |
Kogure D,Matsuda H,Ohnishi T,et al.Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.J Nucl Med,2000,41(7):1155-1162.
|
| [10] |
Encinas M,Juan R,Marcos A,et al.Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.Eur J Nucl Med Mol Imaging,2003,30(11):1473-1480.
|
| [11] |
Okamura N,Arai H,Maruyama M,et al.Combined analysis of CSF Tau levels and[123I] iodoamphetamine SPECT in mild cognitive impairment:implications for a novel predictor of Alzheimer's disease.Am J Psychiatry,2002,159(3):474-476.
|
| [12] |
Drzezga A,Lautenschlager N,Siebner H,et al.Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease:a PET follow-up study.Eur J Nucl Med Mol Imaging,2003,30(8):1104-1113.
|
| [13] |
Small GW,Ercoli LM,Sliverman DH et al.Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.Proc Natl Acad Sci USA,2000,97(11):6037-6042.
|
| [14] |
Chételat G,Desgranges B,de la Sayette V,et al.Mild cognitive impairment can FDG-PET predict who is to rapidly convert to Alzheimei's disease?.Neurology,2003,60(8):1374-1377.
|
| [15] |
Mosconi L,Perani D,Sorbi S,et al.MCI conversion to dementia and the APOE genotype.A prediction study with FDG PET.Neurology,2004,63(12):2332-2340.
|
| [16] |
Arnáiz E,Jelic V,Almkvist O,et al.Impairment cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment.Neuroreport,2001,12(4):851-855.
|